AntiCancer (United States)

Recent papers from AntiCancer (United States)

1. HSP90 shields ROC1/RBX1 from proteasomal degradation by CHIP E3 ubiquitin ligase to promote lung adenocarcinomaSignal Transduction and Targeted Therapy · 2026
2. Synergy of KRAS-inhibitor Daraxonrasib Combined With Recombinant Methioninase on Pancreatic-cancer Cells But Not Normal CellsAnticancer Research · 2026
3. Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specificFrontiers in Oncology · 2026
4. The Phosphatidylinositol 3-Kinase (PI3K) Inhibitor Inavolisib Has Breast-cancer Synergy Combined With Recombinant Methioninase But Not on Normal CellsIn Vivo · 2026
5. Advances in Optical and Fluorescence Imaging for Surgical Management of Thyroid CancerCancers · 2026
6. A Melanoma Transplanted in Nude Mice Has Both Host‐ and Tumor‐Derived Blood Vessel‐ and Nerve‐Like StructuresCancer Science · 2026
7. Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelIn Vivo · 2026
8. Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cellsFrontiers in Oncology · 2026
9. Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon CancerAnticancer Research · 2026
10. The Combination of Methionine Adenosyltransferase 2A (MAT2A) Inhibitor AG-270 and Recombinant Methioninase Is Not Cancer-selective in a Co-culture Model of Colon Cancer Cells and Normal Fibroblasts.2026
11. Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell Carcinoma.2026
12. Serum Extracellular Vesicles Double-positive for CD9 and CD147 or for CD9 and CD63 Decrease After Surgical Resection in Patients With Colorectal Cancer: Potential Biomarkers of Residual Tumor.2026
13. Sulfasalazine an Inhibitor of System xC ⁻ (Cystine/glutamate Antiporter), Combined With Recombinant Methioninase, Inhibits Both Cancer and Normal Cells, Suggesting Lack of Cancer Selectivity of Cysteine Restriction.2026
14. Abstract 2134: Targeting primary gastric tumors and peritoneal metastases in cell-derived xenograft mouse models using an anti-mucin-4-antibody conjugated near infrared fluorophore.Cancer Research · 2026
15. Abstract 5889: Preclinical evaluation of EO1001 in EGFR-ECD mutant solid tumor models: Toward biomarker-directed therapyCancer Research · 2026
16. The Glucose and Glutamine Requirements of Cancer and Normal Cells Do Not Distinguish Them, in Contrast to Their Methionine Requirement, Suggesting the Warburg Effect Is Not a Cancer ParadigmAnticancer Research · 2026
17. Ultra-low Concentrations of Cisplatinum Down to the IC ₁₀ in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In VivoIn Vivo · 2026
18. Sleep Duration and Depression as Predictors of Cancer Incidence in Middle-aged and Older Adults: A Longitudinal Analysis from the China Health and Retirement Longitudinal Study (CHARLS)In Vivo · 2026
19. Methionine Restriction Alone Induces T-cell-mediated Immunotherapy of Osteosarcoma in a Syngeneic Mouse ModelIn Vivo · 2026
20. Glutamine Dependence Is Not a Cancer-specific Vulnerability in Contrast to Methionine DependenceAnticancer Research · 2026